Ya‐Jia Xie
Macau University of Science and Technology(MO)Quality Research(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Immune cells in cancer, Lung Cancer Treatments and Mutations, Immune Cell Function and Interaction, RNA modifications and cancer
Most-Cited Works
- → Ginseng polysaccharides alter the gut microbiota and kynurenine/tryptophan ratio, potentiating the antitumour effect of antiprogrammed cell death 1/programmed cell death ligand 1 (anti-PD-1/PD-L1) immunotherapy(2021)489 cited
- → Luteolin and its derivative apigenin suppress the inducible PD-L1 expression to improve anti-tumor immunity in KRAS-mutant lung cancer(2021)209 cited
- → Evodiamine suppresses non-small cell lung cancer by elevating CD8+ T cells and downregulating the MUC1-C/PD-L1 axis(2020)114 cited
- → β-Elemene enhances erlotinib sensitivity through induction of ferroptosis by upregulating lncRNA H19 in EGFR-mutant non-small cell lung cancer(2023)89 cited
- → Andrographolide suppresses non-small-cell lung cancer progression through induction of autophagy and antitumor immune response(2022)78 cited
- → Chelidonine selectively inhibits the growth of gefitinib-resistant non-small cell lung cancer cells through the EGFR-AMPK pathway(2020)42 cited
- → Dolutegravir derivative inhibits proliferation and induces apoptosis of non-small cell lung cancer cells via calcium signaling pathway(2020)42 cited
- → Plumbagin suppresses non-small cell lung cancer progression through downregulating ARF1 and by elevating CD8+ T cells(2021)41 cited
- → Periodontal Ligament Stem Cell Exosomes Key to Regulate Periodontal Regeneration by miR-31-5p in Mice Model(2023)40 cited
- → Bacteria-based nanodrug for anticancer therapy(2022)23 cited